Lower doses (IC20 EEAG, IC50EEAC, and IC50 EEAL) had a moderate anti-oxidant effect by slightly reducing MDA levels and stimulating catalase activity (Figure 8A), while higher doses (IC40 EEAG, IC80 EEAC, and IC80 EEAL) increased MDA levels in correlation with a proportional increase in the total anti-oxidant capacity of the cancer cells. This evidence concerns the gene CAT and cancer.